NCNO insider files Form 144 to sell 308,003 shares valued at $9.36M
Rhea-AI Filing Summary
nCino, Inc. (NCNO) filed a Form 144 notifying the proposed sale of 308,003 shares of common stock through Merrill Lynch Pierce Fenner and Smith on Nasdaq with an approximate aggregate market value of $9,363,291.20. The shares represent part of 115,814,720 shares outstanding and were originally acquired on 06/15/2020 in a private placement from the issuer, with payment noted as cash. The filing lists an approximate sale date of 09/08/2025. The filer reports no securities sold in the past three months for the same account and includes the standard representation that no undisclosed material adverse information is known to the seller.
Positive
- Full disclosure provided: Form 144 supplies acquisition date, acquisition method (private placement), broker, and aggregate market value
- No recent sales: The filer reports "Nothing to Report" for securities sold in the past three months
Negative
- No seller identity disclosed in the provided extract, limiting assessment of insider role or intent
- Filing lacks information on whether sales are pursuant to a Rule 10b5-1 trading plan or other pre-established arrangement
Insights
TL;DR: Director/insider notice to sell ~0.27% of outstanding shares via broker; procedural disclosure with limited immediate market implication.
The Form 144 documents a planned resale of 308,003 common shares by a person who acquired them in a private placement on 06/15/2020. The aggregate market value is reported as $9,363,291.20 and the sale is to be executed through Merrill Lynch on Nasdaq around 09/08/2025. No sales in the prior three months are reported, which suggests this is a planned, discrete transaction rather than part of a series of recent disposals. This filing is a regulatory notice required when restricted or control securities are to be sold; it does not by itself disclose intent beyond the sale and contains no new material operational or financial data about the issuer.
TL;DR: Routine insider resale notice; important for transparency but not a standalone signal of company performance.
The filing shows the shares were acquired from the issuer in a private placement and are now proposed for sale through an institutional broker. The seller affirms no undisclosed material adverse information. From a governance perspective, the disclosure meets Rule 144 notice requirements and provides market participants with visibility into an insider-level transaction. The document lacks context about the seller's identity, any trading plan, or whether sales are part of a Rule 10b5-1 plan, limiting deeper governance conclusions.